stage iva vulvar cancer ajcc v8
Showing 1 - 4 of 4
Malignant Female Reproductive System Tumor, Stage I Cervical Cancer AJCC v8, Stage I Uterine Corpus Cancer AJCC v8 Trial in
Recruiting
- Malignant Female Reproductive System Neoplasm
- +44 more
- Counseling
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 25, 2022
Human Papillomavirus-16 Positive, Human Papillomavirus-18 Positive, Metastatic Malignant Tumor Trial in Houston (DNA
Active, not recruiting
- Human Papillomavirus-16 Positive
- +20 more
- DNA Plasmid-encoding Interleukin-12/HPV DNA Plasmids Therapeutic Vaccine MEDI0457
- Durvalumab
-
Houston, TexasM D Anderson Cancer Center
Feb 11, 2022
Cervical Adenocarcinoma, Cervical Adenocarcinoma In Situ, Cervical Intraepithelial Neoplasia Trial in Houston (Biospecimen
Recruiting
- Cervical Adenocarcinoma
- +54 more
- Biospecimen Collection
- Laboratory Biomarker Analysis
-
Houston, Texas
- +1 more
Nov 30, 2020
Stage II Vulvar Cancer AJCC v8, Stage III Vulvar Cancer AJCC v8, Stage IIIA Vulvar Cancer AJCC v8 Trial in Houston (Cisplatin,
Recruiting
- Stage II Vulvar Cancer AJCC v8
- +5 more
- Cisplatin
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Sep 18, 2020